Stephenson Cancer Center At The University Of Oklahoma
Strategies can make adjustment to daylight saving time easier, mitigate health impacts
Daylight saving time has been a source of contention and debate since its introduction in 1918.
Novel drug delivery approach may protect against cisplatin-related hearing loss
A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.
Oncologists play key role in diagnosing immune checkpoint inhibitor-induced myocarditis
Incidence of immune checkpoint inhibitor-induced myocarditis may increase as more patients receive immunotherapy. In this special report, Healio | HemOnc Today highlights how a multidisciplinary approach can reduce mortality through early recognition and prompt intervention.
Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer
CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.
Simple hysterectomy safe for early-stage, low-risk cervical cancer
CHICAGO — Pelvic node dissection and simple hysterectomy appeared noninferior to radical hysterectomy at 3 years among women with early-stage, low-risk cervical cancer, according to data from the SHAPE study.
Timely intervention critical for major cardiac events after immune checkpoint therapy
CHICAGO — Patients and prescribers should be more aware of the potential for major adverse cardiac events after immune checkpoint inhibitor-based therapy, according to retrospective study results presented at ASCO Annual Meeting.